You must be 21 years old or 18 years old with a medical card to access this website.
Are you eligible?
You're not old enough to visit Weevader. Please come back when you're 21.
Cannabis produces over 100 unique compounds called cannabinoids, each with distinct effects on the human body. While THC and CBD dominate the headlines, a growing body of research is revealing that minor cannabinoids like CBN, CBG, CBC, and THCV play important roles of their own. This guide breaks down every major cannabinoid, what it does, and why it matters for your cannabis experience.
Cannabinoids are chemical compounds that interact with the endocannabinoid system (ECS) — a network of receptors found throughout the human body. They come in three categories: phytocannabinoids (produced by plants, primarily cannabis), endocannabinoids (produced naturally by the body), and synthetic cannabinoids (made in laboratories). This guide focuses on phytocannabinoids, the ones you'll encounter in cannabis products.
In the living cannabis plant, most cannabinoids exist in their acidic forms — THCA, CBDA, CBGA — which are non-intoxicating. Heat (from smoking, vaping, or baking) converts these acids into their active forms through a process called decarboxylation. This is why raw cannabis doesn't produce a high.
THC is the primary psychoactive cannabinoid in cannabis and the compound responsible for the euphoric high. It binds directly to CB1 receptors in the brain, producing effects that include euphoria, relaxation, altered time perception, increased appetite, and pain relief. THC concentrations in flower typically range from 10% to 30%, though some modern cultivars exceed 35%.
CBD is the second most abundant cannabinoid and is non-intoxicating. It does not bind directly to CB1 or CB2 receptors in the same way THC does. Instead, CBD acts through multiple mechanisms: it modulates CB1 receptors (reducing THC's intensity), inhibits the FAAH enzyme (increasing anandamide levels), and interacts with serotonin receptors (5-HT1A) and vanilloid receptors (TRPV1).
CBN is formed when THC oxidizes and degrades over time — this is why old cannabis tends to make people sleepy. CBN is mildly psychoactive (roughly one-quarter the potency of THC) and is most commonly marketed as a sleep aid, though the scientific evidence for its sedative effects is still limited.
CBG is called the 'mother of all cannabinoids' because its acidic form, CBGA, is the precursor molecule from which all other cannabinoids are synthesized in the plant. Most cannabis strains contain less than 1% CBG by harvest because enzymes have already converted CBGA into THCA, CBDA, or CBCA. However, breeders have developed CBG-dominant strains, and interest in this cannabinoid is surging.
CBC is non-intoxicating and is one of the most abundant cannabinoids in some strains. It interacts with TRPV1 and TRPA1 receptors (involved in pain perception) rather than CB1 or CB2. Research suggests potential anti-inflammatory, antidepressant, and analgesic effects. CBC may also contribute to the entourage effect by enhancing the activity of other cannabinoids.
THCV is structurally similar to THC but with notably different effects. At low doses, THCV acts as a CB1 antagonist — it actually blocks the receptor, which may suppress appetite (the opposite of THC's munchie effect). At higher doses, THCV becomes a CB1 agonist and produces a clear-headed, energetic, shorter-lasting high. THCV-rich strains are popular among those seeking focus and energy without excessive hunger.
THCA and CBDA are the raw, unheated forms of THC and CBD found in fresh cannabis. They are non-intoxicating and have their own distinct therapeutic profiles. THCA shows potential anti-inflammatory and neuroprotective properties. CBDA has demonstrated antiemetic effects (reducing nausea) in preclinical studies, potentially even more effectively than CBD. Juicing raw cannabis preserves these acidic cannabinoids.
Delta-8 THC is a structural isomer of delta-9 THC, differing only in the position of a chemical bond. It produces a milder high — often described as about two-thirds the intensity of delta-9 with less anxiety. While delta-8 occurs naturally in trace amounts, most commercial delta-8 is synthesized from hemp-derived CBD through chemical conversion. Its legal status varies by state.
The relationship between cannabinoids is not simply additive — they modulate and modify each other's effects. CBD reduces THC-induced anxiety by modulating CB1 receptors. CBN combined with THC enhances sedation. CBG may counteract THC-induced paranoia. Understanding these interactions helps consumers choose the right products and strains for their needs.